Author:
Yang Qin,Larsen Stine K.,Mi Zhibao,Robbins Paul D.,Basse Per H.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. C. J. Springer, and I. I. Niculescu-Duvaz. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Adv. Drug. Deliv. Rev. 26:151–172 (1997).
2. G. Xu, and H. L. McLeod. Strategies for enzyme/prodrug cancer therapy. Clin. Cancer Res. 7:3314–3324 (2001).
3. D. C. Blakey, D. H. Davies, R. I. Dowell, S. J. East, P. J. Burke, S. K. Sharma, C. J. Springer, A. B. Mauger, and R. G. Melton. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. Br. J. Cancer. 72:1083–1088 (1995).
4. C. J. Springer, K. D. Bagshawe, S. K. Sharma, F. Searle, J. A. Boden, P. Antoniw, P. J. Burke, G. T. Rogers, R. F. Sherwood, and R. G. Melton. Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. Eur. J. Cancer. 27:1361–1366 (1991).
5. K. D. Bagshawe, S. K. Sharma, C. J. Springer, P. Antoniw, J. A. Boden, G. T. Rogers, P. J. Burke, R. G. Melton, and R. F. Sherwood. Antibody directed enzyme prodrug therapy (ADEPT): clinical report. Dis. Markers. 9:233–238 (1991).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献